This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
NIVESTYM® (filgrastim-aafi) is a biosimilar to Neupogen® (filgrastim) and part of the largest oncology biosimilars portfolio, brought to you by Pfizer
NIVESTYM® (filgrastim-aafi) is a biosimilar to Neupogen®
(filgrastim) and part of the largest oncology biosimilars portfolio,
brought to you by Pfizer
Dosing, resources, and biosimilars portfolio
Resources for your practice and patients
View reimbursement, educational, and patient materials
Find videos and on-demand webinars
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.